Bowers CY et al., Ann NY Acad Sci, 1998 865:244-249
Lillys Easy-to Use Once-Weekly GLP-1 Agonist Trulicity Approved in Europe Twitter Summary: Lillys Trulicity, a once-weekly GLP-1 agonist available in US, has now been approved in Europe On November 25, Eli Lillys Trulicity (dulaglutide) was approved in Europe for type 2 diabetes
How it was supposed to work Originally, the short-term program was meant to be a bridge to a longer-term solution
Rights and permissions About this article Cite this article Novakova, K., Kummer, O., Bouitbir, J
Funding S.J.P., D.K., and M.D